What You Should Know:
– Mount Sinai Fuster Heart Hospital has announced the launch of The Samuel Fineman Cardiac Catheterization Artificial Intelligence (AI) Research Lab. The new AI lab will use the hospital’s renowned Cardiac Catheterization Lab to advance interventional cardiology and enhance patient care and outcomes.
– Dr. Annapoorna Kini will serve as the Director of the new AI lab. She also directs The Mount Sinai Hospital’s Cardiac Catheterization Lab, which is internationally recognized for its exceptional safety and expertise in complex cases.
Catheterization AI Research Lab Focus
The new lab will focus on many aspects of interventional cardiology, from procedural to educational. Through internal and external collaborations, the lab will explore existing data to gain insights that can significantly impact how healthcare is delivered. AI has the capability to spur new levels of innovation in areas like risk stratification, case planning, and optimizing outcomes.
“While AI is not a magic solution to every problem, there are many places it can make a notable improvement over traditional techniques or bring some approaches that were never possible within reach. In five or so years, we think that many workflows can be augmented by AI to better focus our resources where they are most needed,” says Dr. Kini.
The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab was established in memory of Samuel Fineman, who passed away in 2021. His generous gift was a show of appreciation for the care he received from Dr. Samin K. Sharma.
